RESEARCH. CONNECTED.

Explore the scholarly record.

Discover prefix ownership, publishers, journals and DOI metadata. Understand the data behind every publication.

DOI RECORD

Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström's Macroglobulinemia

R García-Sanz, EM Ocio, A Caballero, R J P Magalhães, J Alonso, L López-Anglada, T Villaescusa, N Puig, J M Hernández, J Fernández-Calvo, A Aguilar, A Martín, R López, B Paiva, A Orfao, B Vidriales, J F San-Miguel, D. del Carpio

DOI10.3816/clml.2011.n.040

PublisherElsevier BV

Journal / SourceClinical Lymphoma Myeloma and Leukemia

Published2011-02

Metadata Deposited2012-11-13 (updated: 2025-10-31)

Subject—

Languageen

ISSN2152-2650

Typejournal-article

Volume / Issue / Pages11 / 1 / 168-171

Citations20

References deposited16

Access / license metadataRestricted reuse / TDM license License 1 ↗ License 2 ↗A reuse license does not by itself establish whether the full text is freely readable.

Open DOI

Explore the scholarly record.

Post-Treatment Bone Marrow Residual Disease &gt; 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström's Macroglobulinemia

Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström's Macroglobulinemia